Kercheville Advisors LLC lessened its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 66.9% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 5,870 shares of the exchange traded fund’s stock after selling 11,850 shares during the period. Kercheville Advisors LLC’s holdings in SPDR S&P Biotech ETF were worth $750,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other large investors have also recently modified their holdings of the company. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC acquired a new stake in SPDR S&P Biotech ETF in the 4th quarter worth approximately $27,000. Intesa Sanpaolo Wealth Management acquired a new position in SPDR S&P Biotech ETF during the 4th quarter valued at approximately $30,000. SHP Wealth Management acquired a new position in SPDR S&P Biotech ETF during the 4th quarter valued at approximately $31,000. Legacy Wealth Managment LLC ID purchased a new position in shares of SPDR S&P Biotech ETF in the fourth quarter worth $32,000. Finally, Smartleaf Asset Management LLC acquired a new stake in shares of SPDR S&P Biotech ETF during the fourth quarter worth $32,000.
SPDR S&P Biotech ETF Trading Up 0.8%
NYSEARCA:XBI opened at $147.03 on Wednesday. The company has a market capitalization of $9.38 billion, a P/E ratio of 11.47 and a beta of 0.85. SPDR S&P Biotech ETF has a 12 month low of $82.04 and a 12 month high of $148.76. The firm has a fifty day simple moving average of $134.19 and a 200-day simple moving average of $128.13.
SPDR S&P Biotech ETF Company Profile
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.
Featured Stories
- Five stocks we like better than SPDR S&P Biotech ETF
- Oracle’s Sell-Off Looks More Like a Mispricing Than a Warning
- Apple’s Intel Deal Arrives at the Right Time for Its Stock
- Liquid Gold: The AI Cooling Retrofit Trade
- 3 Dividend Stocks Under $30 to Anchor Your Portfolio
Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report).
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.
